Signaling mechanism of cell adhesion molecules in breast cancer metastasis: Potential therapeutic targets

Breast Cancer Research and Treatment

Volumn 128, Issue 1, 2011, Pages 7-21

  Li, Dong Mei ^a   Feng, Yu Mei ^a,b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Breast cancer; Cell adhesion molecules; Metastasis

Indexed keywords

ANTINEOPLASTIC AGENT; CADHERIN; CELL ADHESION MOLECULE; CILENGITIDE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EOS 200 4; ETARACIZUMAB; EXHERIN; HERMES ANTIGEN; IMMUNOGLOBULIN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTETUMUMAB; L SELECTIN; N ACETYLPROLYLHISTIDYLSERYLCYSTEINYLASPARAGINE AMIDE; NERVE CELL ADHESION MOLECULE; NSC 707544; P CADHERIN; PADGEM PROTEIN; R CADHERIN; SELECTIN; UNCLASSIFIED DRUG; UVOMORULIN; VASCULAR ENDOTHELIAL CADHERIN; VOLOCIXIMAB;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; BRAIN TUMOR; BREAST CANCER; BREAST METASTASIS; CELL ADHESION; CELL INVASION; CELL MIGRATION; DRUG PROTEIN BINDING; GYNECOLOGIC CANCER; HUMAN; KIDNEY CARCINOMA; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; MELANOMA; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; SOLID TUMOR; TUMOR CELL; TUMOR VASCULARIZATION;

ANIMALS; BREAST NEOPLASMS; CADHERINS; CELL ADHESION MOLECULES; FEMALE; HUMANS; INTEGRINS; MOLECULAR TARGETED THERAPY; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; SELECTINS; SIGNAL TRANSDUCTION;

EID: 79959255482     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1499-x     Document Type: Review

References (138)

1. N Makrilia A Kollias L Manolopoulos K Syrigos 2009 Cell adhesion molecules: role and clinical significance in cancer Cancer Investig 27 1023 1037 1:CAS:528:DC%2BD1MXhsVCkurnL
2. R Gonzalez-Amaro F Sanchez-Madrid 1999 Cell adhesion molecules: selectins and integrins Crit Rev Immunol 19 389 429 10647744 1:CAS:528: DC%2BD3cXnvF2ksg%3D%3D (Pubitemid 30053172)
3. AI Rojas AR Ahmed 1999 Adhesion receptors in health and disease Crit Rev Oral Biol Med 10 337 358 10759413 1:STN:280:DC%2BD3c3itFWltQ%3D%3D (Pubitemid 29451179)
4. AW Koch KL Manzur W Shan 2004 Structure-based models of cadherin-mediated cell adhesion: the evolution continues Cell Mol Life Sci 61 1884 1895 15289931 1:CAS:528:DC%2BD2cXnsVWgtL8%3D (Pubitemid 39094796)
5. JM Halbleib WJ Nelson 2006 Cadherins in development: cell adhesion, sorting, and tissue morphogenesis Genes Dev 20 3199 3214 17158740 1:CAS:528:DC%2BD28XhtlSmt7vJ (Pubitemid 44904842)
6. U Cavallaro G Christofori 2004 Cell adhesion and signalling by cadherins and Ig-CAMs in cancer Nat Rev Cancer 4 118 132 14964308 1:CAS:528: DC%2BD2cXhtlaquro%3D (Pubitemid 38198740)
7. S Pokutta WI Weis 2007 Structure and mechanism of cadherins and catenins in cell-cell contacts Annu Rev Cell Dev Biol 23 237 261 17539752 1:CAS:528:DC%2BD2sXhtlartr3O
8. N Rivard 2009 Phosphatidylinositol 3-kinase: a key regulator in adherens junction formation and function Front Biosci 14 510 522 19273082 1:CAS:528:DC%2BD1MXltFejsbs%3D
9. N Ishiyama SH Lee S Liu GY Li MJ Smith LF Reichardt M Ikura 2010 Dynamic and static interactions between p120 catenin and E-cadherin regulate the stability of cell-cell adhesion Cell 141 117 128 20371349 1:CAS:528: DC%2BC3cXlsVSgtbs%3D
10. SA Mousa 2008 Cell adhesion molecules: potential therapeutic & diagnostic implications Mol Biotechnol 38 33 40 18095189 1:CAS:528: DC%2BD1cXmtFGisw%3D%3D (Pubitemid 351378095)
11. M Herzig F Savarese M Novatchkova H Semb G Christofori 2007 Tumor progression induced by the loss of E-cadherin independent of beta-catenin/Tcf-mediated Wnt signaling Oncogene 26 2290 2298 17043652 1:CAS:528:DC%2BD2sXjvVaqsrs%3D (Pubitemid 46572820)
12. E Matteucci E Ridolfi MA Desiderio 2006 Hepatocyte growth factor differently influences Met-E-cadherin phosphorylation and downstream signaling pathway in two models of breast cells Cell Mol Life Sci 63 2016 2026 16909210 1:CAS:528:DC%2BD28XhtVCjt7%2FN (Pubitemid 44359742)
13. S Orsulic O Huber H Aberle S Arnold R Kemler 1999 E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation J Cell Sci 112 Pt 8 1237 1245 10085258 1:CAS:528: DyaK1MXjtFGhsLk%3D (Pubitemid 29218912)
14. AS Wong BM Gumbiner 2003 Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin J Cell Biol 161 1191 1203 12810698 1:CAS:528:DC%2BD3sXkvFCms78%3D (Pubitemid 36870179)
15. T Shibata A Kokubu S Sekine Y Kanai S Hirohashi 2004 Cytoplasmic p120ctn regulates the invasive phenotypes of E-cadherin-deficient breast cancer Am J Pathol 164 2269 2278 15161659 1:CAS:528:DC%2BD2cXltFymtr4%3D (Pubitemid 38669372)
16. PA Pennisi V Barr NP Nunez B Stannard D Le Roith 2002 Reduced expression of insulin-like growth factor I receptors in MCF-7 breast cancer cells leads to a more metastatic phenotype Cancer Res 62 6529 6537 12438247 1:CAS:528:DC%2BD38XovFOksrg%3D (Pubitemid 35364118)
17. TT Onder PB Gupta SA Mani J Yang ES Lander RA Weinberg 2008 Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways Cancer Res 68 3645 3654 18483246 1:CAS:528:DC%2BD1cXlvVOitLw%3D
18. HM Dong G Liu J Wu JS Lu JM Luo ZZ Shen ZM Shao 2006 Biological significance of E-cadherin in an inflammatory breast carcinoma cell line Zhonghua Zhong Liu Za Zhi 28 4 7 16737610
19. MA Huber N Kraut H Beug 2005 Molecular requirements for epithelial-mesenchymal transition during tumor progression Curr Opin Cell Biol 17 548 558 16098727 1:CAS:528:DC%2BD2MXhtVWnsb7L (Pubitemid 41267170)
20. RB Hazan GR Phillips RF Qiao L Norton SA Aaronson 2000 Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis J Cell Biol 148 779 790 10684258 1:CAS:528: DC%2BD3cXhsVOqsLw%3D
21. MT Nieman RS Prudoff KR Johnson MJ Wheelock 1999 N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression J Cell Biol 147 631 644 10545506 1:CAS:528:DC%2BD3cXislyqsrw%3D
22. JB Kim S Islam YJ Kim RS Prudoff KM Sass MJ Wheelock KR Johnson 2000 N-Cadherin extracellular repeat 4 mediates epithelial to mesenchymal transition and increased motility J Cell Biol 151 1193 1206 11121435 1:CAS:528: DC%2BD3cXovFantL4%3D
23. K Suyama I Shapiro M Guttman RB Hazan 2002 A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor Cancer Cell 2 301 314 12398894 1:CAS:528:DC%2BD38Xot1Gkt7g%3D (Pubitemid 41043964)
24. J Hulit K Suyama S Chung R Keren G Agiostratidou W Shan X Dong TM Williams MP Lisanti K Knudsen RB Hazan 2007 N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation Cancer Res 67 3106 3116 17409417 1:CAS:528:DC%2BD2sXksVGlurk%3D (Pubitemid 46724847)
25. P Navarro L Ruco E Dejana 1998 Differential localization of VE- and N-cadherins in human endothelial cells: VE-cadherin competes with N-cadherin for junctional localization J Cell Biol 140 1475 1484 9508779 1:CAS:528: DyaK1cXitFChsLw%3D (Pubitemid 28152995)
26. I Ramis-Conde MA Chaplain AR Anderson D Drasdo 2009 Multi-scale modelling of cancer cell intravasation: the role of cadherins in metastasis Phys Biol 6 016008 19321920
27. H Li DK Price WD Figg 2007 ADH1, an N-cadherin inhibitor, evaluated in preclinical models of angiogenesis and androgen-independent prostate cancer Anticancer Drugs 18 563 568 17414625 1:CAS:528:DC%2BD2sXjvVKiu7g%3D (Pubitemid 46597411)
28. L Kelland 2007 Drug evaluation: ADH-1, an N-cadherin antagonist targeting cancer vascularization Curr Opin Mol Ther 9 86 91 17330406 1:CAS:528: DC%2BD2sXjt1Sgtr8%3D (Pubitemid 46438451)
29. Y Shintani Y Fukumoto N Chaika PM Grandgenett MA Hollingsworth MJ Wheelock KR Johnson 2008 ADH-1 suppresses N-cadherin-dependent pancreatic cancer progression Int J Cancer 122 71 77 17721921 1:CAS:528:DC%2BD2sXhsVSgtbzL (Pubitemid 350209980)
30. A Perotti C Sessa A Mancuso C Noberasco S Cresta A Locatelli ML Carcangiu K Passera A Braghetti D Scaramuzza F Zanaboni A Fasolo G Capri M Miani WP Peters L Gianni 2009 Clinical and pharmacological phase I evaluation of Exherin (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours Ann Oncol 20 741 745 19190075 1:STN:280:DC%2BD1M3jt1Gjtw%3D%3D
31. Y Wallez I Vilgrain P Huber 2006 Angiogenesis: the VE-cadherin switch Trends Cardiovasc Med 16 55 59 16473763 1:CAS:528:DC%2BD28Xhtlaltbs%3D (Pubitemid 43214527)
32. BS Parker P Argani BP Cook H Liangfeng SD Chartrand M Zhang S Saha A Bardelli Y Jiang TB St Martin M Nacht BA Teicher KW Klinger S Sukumar SL Madden 2004 Alterations in vascular gene expression in invasive breast carcinoma Cancer Res 64 7857 7866 15520192 1:CAS:528:DC%2BD2cXptFelsr8%3D (Pubitemid 39446919)
33. F Liao Y Li W O'Connor L Zanetta R Bassi A Santiago J Overholser A Hooper P Mignatti E Dejana DJ Hicklin P Bohlen 2000 Monoclonal antibody to vascular endothelial-cadherin is a potent inhibitor of angiogenesis, tumor growth, and metastasis Cancer Res 60 6805 6810 11156369 1:CAS:528:DC%2BD3MXjsVKrsg%3D%3D (Pubitemid 32059142)
34. M Corada L Zanetta F Orsenigo F Breviario MG Lampugnani S Bernasconi F Liao DJ Hicklin P Bohlen E Dejana 2002 A monoclonal antibody to vascular endothelial-cadherin inhibits tumor angiogenesis without side effects on endothelial permeability Blood 100 905 911 12130501 1:CAS:528: DC%2BD38XlvVCltL0%3D (Pubitemid 34832616)
35. A Sahni MT Arevalo SK Sahni PJ Simpson-Haidaris 2009 The VE-cadherin binding domain of fibrinogen induces endothelial barrier permeability and enhances transendothelial migration of malignant breast epithelial cells Int J Cancer 125 577 584 19358279 1:CAS:528:DC%2BD1MXmsleqsLk%3D
36. M Labelle HJ Schnittler DE Aust K Friedrich G Baretton D Vestweber G Breier 2008 Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor beta signaling Cancer Res 68 1388 1397 18316602 1:CAS:528:DC%2BD1cXislaguro%3D (Pubitemid 351346846)
37. A Nose Y Shirayoshi M Takeichi 1986 Expression pattern of E-cadherin and P-cadherin associated with morphogenesis of mouse embryos Dev Growth Differ 28 389 390
38. J Paredes AL Correia AS Ribeiro A Albergaria F Milanezi FC Schmitt 2007 P-cadherin expression in breast cancer: a review Breast Cancer Res 9 214 18001487
39. G Turashvili SE McKinney O Goktepe SC Leung DG Huntsman KA Gelmon G Los PA Rejto SA Aparicio 2011 P-cadherin expression as a prognostic biomarker in a 3992 case tissue microarray series of breast cancer Mod Pathol 24 64 81 20852590 1:CAS:528:DC%2BC3MXht1KgsA%3D%3D
40. AS Ribeiro A Albergaria B Sousa AL Correia M Bracke R Seruca FC Schmitt J Paredes 2010 Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells Oncogene 29 392 402 19901964 1:CAS:528:DC%2BD1MXhtlynt7rF
41. J Paredes C Stove V Stove F Milanezi V Van Marck L Derycke M Mareel M Bracke F Schmitt 2004 P-cadherin is up-regulated by the antiestrogen ICI 182, 780 and promotes invasion of human breast cancer cells Cancer Res 64 8309 8317 15548699 1:CAS:528:DC%2BD2cXpvVGlu7g%3D (Pubitemid 39491769)
42. G Agiostratidou M Li K Suyama I Badano R Keren S Chung A Anzovino J Hulit B Qian B Bouzahzah E Eugenin O Loudig GR Phillips J Locker RB Hazan 2009 Loss of retinal cadherin facilitates mammary tumor progression and metastasis Cancer Res 69 5030 5038 19491271 1:CAS:528:DC%2BD1MXnt1eqtbo%3D
43. E Johnson CS Theisen KR Johnson MJ Wheelock 2004 R-cadherin influences cell motility via Rho family GTPases J Biol Chem 279 31041 31049 15143071 1:CAS:528:DC%2BD2cXlslOktbg%3D (Pubitemid 39037764)
44. M Maeda E Johnson SH Mandal KR Lawson SA Keim RA Svoboda S Caplan JK Wahl III MJ Wheelock KR Johnson 2006 Expression of inappropriate cadherins by epithelial tumor cells promotes endocytosis and degradation of E-cadherin via competition for p120(ctn) Oncogene 25 4595 4604 16786001 1:CAS:528: DC%2BD28Xnsl2jsLk%3D (Pubitemid 44175118)
45. H Laubli L Borsig 2010 Selectins promote tumor metastasis Semin Cancer Biol 20 3 169 177 20452433
46. GS Kansas 1996 Selectins and their ligands: current concepts and controversies Blood 88 3259 3287 8896391 1:CAS:528:DyaK28XmsFKksL4%3D (Pubitemid 26365560)
47. SS Pinho AJ Matos C Lopes NT Marcos J Carvalheira CA Reis F Gartner 2007 Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-cadherin expression BMC Cancer 7 124 17617904
48. SS Pinho CA Reis F Gartner ML Alpaugh 2009 Molecular plasticity of E-cadherin and sialyl lewis x expression, in two comparative models of mammary tumorigenesis PLoS One 4 e6636 19675678
49. U Jeschke I Mylonas N Shabani C Kunert-Keil C Schindlbeck B Gerber K Friese 2005 Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis Anticancer Res 25 1615 1622 16033070 1:CAS:528:DC%2BD2MXmsVCrtbg%3D (Pubitemid 40896773)
50. K Ley C Laudanna MI Cybulsky S Nourshargh 2007 Getting to the site of inflammation: the leukocyte adhesion cascade updated Nat Rev Immunol 7 678 689 17717539 1:CAS:528:DC%2BD2sXpsV2qtb0%3D (Pubitemid 47327397)
51. SR Barthel JD Gavino L Descheny CJ Dimitroff 2007 Targeting selectins and selectin ligands in inflammation and cancer Expert Opin Ther Targets 11 1473 1491 18028011 1:CAS:528:DC%2BD2sXht1amsbnK (Pubitemid 350200482)
52. J Wei L Cui F Liu Y Fan R Lang F Gu X Guo P Tang L Fu 2010 E-selectin and Sialyl Lewis X expression is associated with lymph node metastasis of invasive micropapillary carcinoma of the breast Int J Surg Pathol 18 193 200 18611928
53. OG Shaker MA Ay El-Deen MT Abd El-Rahim RM Talaat 2006 Gene expression of E-selectin in tissue and its protein level in serum of breast cancer patients Tumori 92 524 530 17260494 1:CAS:528:DC%2BD2sXhvFSns7o%3D (Pubitemid 46166306)
54. N Vannini U Pfeffer G Lorusso DM Noonan A Albini 2008 Endothelial cell aging and apoptosis in prevention and disease: E-selectin expression and modulation as a model Curr Pharm Des 14 221 225 18220832 1:CAS:528: DC%2BD1cXisFSntr0%3D (Pubitemid 351516866)
55. RM Lafrenie S Gallo TJ Podor MR Buchanan FW Orr 1994 The relative roles of vitronectin receptor, E-selectin and alpha 4 beta 1 in cancer cell adhesion to interleukin-1-treated endothelial cells Eur J Cancer 30A 2151 2158 7531992 1:CAS:528:DyaK2MXksFagu78%3D
56. A Tozeren HK Kleinman DS Grant D Morales AM Mercurio SW Byers 1995 E-selectin-mediated dynamic interactions of breast- and colon-cancer cells with endothelial-cell monolayers Int J Cancer 60 426 431 7530236 1:CAS:528: DyaK2MXks1SgsLw%3D
57. T Narita N Kawasaki-Kimura N Matsuura H Funahashi R Kannagi 1996 Adhesion of human breast cancer cells to vascular endothelium mediated by sialyl Lewis &supx;/E-selectin Breast Cancer 3 19 23 11091549
58. K Yuan D Kucik RK Singh CM Listinsky JJ Listinsky GP Siegal 2008 Alterations in human breast cancer adhesion-motility in response to changes in cell surface glycoproteins displaying alpha-L-fucose moieties Int J Oncol 32 797 807 18360707 1:CAS:528:DC%2BD1cXkslOitrs%3D (Pubitemid 351780590)
59. K Zen DQ Liu YL Guo C Wang J Shan M Fang CY Zhang Y Liu 2008 CD44v4 is a major E-selectin ligand that mediates breast cancer cell transendothelial migration PLoS One 3 e1826 18350162
60. Y Shamay D Paulin G Ashkenasy A David 2009 E-selectin binding peptide-polymer-drug conjugates and their selective cytotoxicity against vascular endothelial cells Biomaterials 30 6460 6468 19716600 1:CAS:528:DC%2BD1MXhtFCktLrI
61. M Hirai Y Hiramatsu S Iwashita T Otani L Chen YG Li M Okada K Oie K Igarashi H Wakita M Seno 2010 E-selectin targeting to visualize tumors in vivo Contrast Media Mol Imaging 5 70 77 20235150 1:CAS:528:DC%2BC3cXltFKisLY%3D
62. GF Nash LF Turner MF Scully AK Kakkar 2002 Platelets and cancer Lancet Oncol 3 425 430 12142172 1:CAS:528:DC%2BD38Xls1Wisr0%3D (Pubitemid 36958273)
63. YJ Kim L Borsig NM Varki A Varki 1998 P-selectin deficiency attenuates tumor growth and metastasis Proc Natl Acad Sci USA 95 9325 9330 9689079 1:CAS:528:DyaK1cXltlCmurc%3D (Pubitemid 28506230)
64. L Borsig R Wong J Feramisco DR Nadeau NM Varki A Varki 2001 Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis Proc Natl Acad Sci USA 98 3352 3357 11248082 1:CAS:528:DC%2BD3MXit1altrc%3D (Pubitemid 32220849)
65. SB Fox GD Turner KC Gatter AL Harris 1995 The increased expression of adhesion molecules ICAM-3, E- and P-selectins on breast cancer endothelium J Pathol 177 369 376 8568591 1:STN:280:DyaK287msFSqsQ%3D%3D
66. GJ Caine GY Lip AD Blann 2004 Platelet-derived VEGF, Flt-1, angiopoietin-1 and P-selectin in breast and prostate cancer: further evidence for a role of platelets in tumour angiogenesis Ann Med 36 273 277 15224653 1:CAS:528:DC%2BD2cXksVKmtbw%3D (Pubitemid 38789281)
67. AD Blann D Gurney M Wadley D Bareford P Stonelake GY Lip 2001 Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with fibrinogen, plasminogen activator inhibitor and von Willebrand factor Blood Coagul Fibrinolysis 12 43 50 11229826 1:CAS:528: DC%2BD3MXhtVaqsLY%3D (Pubitemid 32150251)
68. S Aigner CL Ramos A Hafezi-Moghadam MB Lawrence J Friederichs P Altevogt K Ley 1998 CD24 mediates rolling of breast carcinoma cells on P-selectin FASEB J 12 1241 1251 9737727 1:CAS:528:DyaK1cXlvFWrsrY%3D (Pubitemid 28418954)
69. B Monzavi-Karbassi JS Stanley L Hennings F Jousheghany C Artaud S Shaaf T Kieber-Emmons 2007 Chondroitin sulfate glycosaminoglycans as major P-selectin ligands on metastatic breast cancer cell lines Int J Cancer 120 1179 1191 17154173 1:CAS:528:DC%2BD2sXhvVOjur4%3D
70. SD Rosen 2004 Ligands for L-selectin: homing, inflammation, and beyond Annu Rev Immunol 22 129 156 15032576 1:CAS:528:DC%2BD2cXktlOgs78%3D (Pubitemid 38680420)
71. H Laubli JL Stevenson A Varki NM Varki L Borsig 2006 L-selectin facilitation of metastasis involves temporal induction of Fut7-dependent ligands at sites of tumor cell arrest Cancer Res 66 1536 1542 16452210 (Pubitemid 43259935)
72. B Qian Y Deng JH Im RJ Muschel Y Zou J Li RA Lang JW Pollard 2009 A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth PLoS One 4 e6562 19668347
73. R Rathinam SK Alahari 2010 Important role of integrins in the cancer biology Cancer Metastasis Rev 29 223 237 20112053 1:CAS:528:DC%2BC3cXitVOjt7g%3D
74. D Harburger D Calderwood 2009 Integrin signalling at a glance J Cell Sci 122 159 163 19118207 1:CAS:528:DC%2BD1MXit1GqtLw%3D
75. L Mauro D Sisci M Bartucci M Salerno J Kim T Tam MA Guvakova S Ando E Surmacz 1999 SHC-alpha5beta1 integrin interactions regulate breast cancer cell adhesion and motility Exp Cell Res 252 439 448 10527634 1:CAS:528: DyaK1MXms1ygsL0%3D (Pubitemid 29530274)
76. Y Imanishi B Hu MJ Jarzynka P Guo E Elishaev I Bar-Joseph SY Cheng 2007 Angiopoietin-2 stimulates breast cancer metastasis through the alpha(5)beta(1) integrin-mediated pathway Cancer Res 67 4254 4263 17483337 1:CAS:528: DC%2BD2sXltVyrs7Y%3D (Pubitemid 46815072)
77. Bianchi A, Gervasi ME, Bakin AV (2010) Role of beta5-integrin in epithelial-mesenchymal transition in response to TGFbeta. Cell Cycle 9
78. JD Hood DA Cheresh 2002 Role of integrins in cell invasion and migration Nat Rev Cancer 2 91 100 12635172 (Pubitemid 37328796)
79. MZ Gilcrease X Zhou X Lu WA Woodward BE Hall PJ Morrissey 2009 Alpha6beta4 integrin crosslinking induces EGFR clustering and promotes EGF-mediated Rho activation in breast cancer J Exp Clin Cancer Res 28 67 19470173
80. G Morozevich N Kozlova I Cheglakov N Ushakova A Berman 2009 Integrin alpha5beta1 controls invasion of human breast carcinoma cells by direct and indirect modulation of MMP-2 collagenase activity Cell Cycle 8 2219 2225 19617714 1:CAS:528:DC%2BC3cXhslKgt7Y%3D
81. K Mitchell KB Svenson WM Longmate K Gkirtzimanaki R Sadej X Wang J Zhao AG Eliopoulos F Berditchevski CM Dipersio 2010 Suppression of integrin alpha3beta1 in breast cancer cells reduces cyclooxygenase-2 gene expression and inhibits tumorigenesis, invasion, and cross-talk to endothelial cells Cancer Res 70 6359 6367 20631072 1:CAS:528:DC%2BC3cXpsVCnurk%3D
82. TL Larkins M Nowell S Singh GL Sanford 2006 Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression BMC Cancer 6 181 16831226
83. M Rolli E Fransvea J Pilch A Saven B Felding-Habermann 2003 Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells Proc Natl Acad Sci USA 100 9482 9487 12874388 1:CAS:528:DC%2BD3sXmtlykurs%3D (Pubitemid 37033954)
84. O Baum R Hlushchuk A Forster R Greiner P Clezardin Y Zhao V Djonov G Gruber 2007 Increased invasive potential and up-regulation of MMP-2 in MDA-MB-231 breast cancer cells expressing the beta3 integrin subunit Int J Oncol 30 325 332 17203213 1:CAS:528:DC%2BD2sXhvFyrtbs%3D
85. Z Mi H Guo PY Wai C Gao PC Kuo 2006 Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells Carcinogenesis 27 1134 1145 16474180 1:CAS:528:DC%2BD28XmsVOku7s%3D (Pubitemid 43985428)
86. B Felding-Habermann TE O'Toole JW Smith E Fransvea ZM Ruggeri MH Ginsberg PE Hughes N Pampori SJ Shattil A Saven BM Mueller 2001 Integrin activation controls metastasis in human breast cancer Proc Natl Acad Sci USA 98 1853 1858 11172040 1:CAS:528:DC%2BD3MXhsVWisLs%3D (Pubitemid 32165587)
87. N Gomes J Vassy C Lebos B Arbeille C Legrand F Fauvel-Lafeve 2004 Breast adenocarcinoma cell adhesion to the vascular subendothelium in whole blood and under flow conditions: effects of alphavbeta3 and alphaIIbbeta3 antagonists Clin Exp Metastasis 21 553 561 15679053 1:CAS:528:DC%2BD2MXhtlKrtro%3D
88. EK Sloan N Pouliot KL Stanley J Chia JM Moseley DK Hards RL Anderson 2006 Tumor-specific expression of alphavbeta3 integrin promotes spontaneous metastasis of breast cancer to bone Breast Cancer Res 8 R20 16608535
89. M Abdel-Ghany HC Cheng RC Elble BU Pauli 2001 The breast cancer beta 4 integrin and endothelial human CLCA2 mediate lung metastasis J Biol Chem 276 25438 25446 11320086 1:CAS:528:DC%2BD3MXlt1ansbw%3D
90. G Serini L Napione M Arese F Bussolino 2008 Besides adhesion: new perspectives of integrin functions in angiogenesis Cardiovasc Res 78 213 222 18285512 1:CAS:528:DC%2BD1cXmt1Wrtbs%3D (Pubitemid 351556107)
91. CJ Avraamides B Garmy-Susini JA Varner 2008 Integrins in angiogenesis and lymphangiogenesis Nat Rev Cancer 8 604 617 18497750 1:CAS:528: DC%2BD1cXovV2lsr0%3D
92. B Garmy-Susini JA Varner 2008 Roles of integrins in tumor angiogenesis and lymphangiogenesis Lymphat Res Biol 6 155 163 19093788 1:CAS:528: DC%2BD1cXhsFajsbvK
93. PR Somanath NL Malinin TV Byzova 2009 Cooperation between integrin alphavbeta3 and VEGFR2 in angiogenesis Angiogenesis 12 177 185 19267251 1:CAS:528:DC%2BD1MXnt12ntLg%3D
94. N Boudreau C Myers 2003 Breast cancer-induced angiogenesis: multiple mechanisms and the role of the microenvironment Breast Cancer Res 5 140 146 12793895 1:CAS:528:DC%2BD3sXjt12jurc%3D (Pubitemid 36519407)
95. M Germain A De Arcangelis SD Robinson M Baker B Tavora G D'Amico R Silva V Kostourou LE Reynolds A Watson JL Jones E Georges-Labouesse K Hodivala-Dilke 2010 Genetic ablation of the alpha 6-integrin subunit in Tie1Cre mice enhances tumour angiogenesis J Pathol 220 370 381 19967723 1:CAS:528:DC%2BC3cXhvFWqt7w%3D
96. J Chung S Yoon K Datta RE Bachelder AM Mercurio 2004 Hypoxia-induced vascular endothelial growth factor transcription and protection from apoptosis are dependent on alpha6beta1 integrin in breast carcinoma cells Cancer Res 64 4711 4716 15256436 1:CAS:528:DC%2BD2cXls1Oms7c%3D (Pubitemid 38924511)
97. SO Yoon S Shin AM Mercurio 2005 Hypoxia stimulates carcinoma invasion by stabilizing microtubules and promoting the Rab11 trafficking of the alpha6beta4 integrin Cancer Res 65 2761 2769 15805276 1:CAS:528:DC%2BD2MXjtVeqsbk%3D (Pubitemid 40490078)
98. YH Soung JL Clifford J Chung 2010 Crosstalk between integrin and receptor tyrosine kinase signaling in breast carcinoma progression BMB Rep 43 311 318 20510013 1:CAS:528:DC%2BC3cXotlahu7g%3D
99. A Oloumi T McPhee S Dedhar 2004 Regulation of E-cadherin expression and beta-catenin/Tcf transcriptional activity by the integrin-linked kinase Biochimica Et Biophysica Acta-Molecular Cell Research 1691 1 15 1:CAS:528:DC%2BD2cXisF2gtL8%3D (Pubitemid 38410945)
100. P Hersey J Sosman S O'Day J Richards A Bedikian R Gonzalez W Sharfman R Weber T Logan M Buzoianu L Hammershaimb JM Kirkwood 2010 A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin alpha(v)beta(3), + or - dacarbazine in patients with stage IV metastatic melanoma Cancer 116 1526 1534 20108344 1:CAS:528:DC%2BC3cXktFGgsLk%3D
101. SJ Moschos CA Sander W Wang SL Reppert LM Drogowski DM Jukic UN Rao C Athanassiou M Buzoianu M Mandic L Richman L McKinney J Leininger DA Tice L Hammershaimb JM Kirkwood 2010 Pharmacodynamic (phase 0) study using etaracizumab in advanced melanoma J Immunother 33 316 325 20445352 1:CAS:528: DC%2BC3cXltFGnsrs%3D
102. W Cai Y Wu K Chen Q Cao DA Tice X Chen 2006 In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin alpha v beta 3 Cancer Res 66 9673 9681 17018625 1:CAS:528:DC%2BD28XhtVams73J (Pubitemid 44623667)
103. Z Liu B Jia H Zhao X Chen F Wang 2010 Specific Targeting of human integrin alpha(v)beta (3) with (111)In-labeled Abegrin in nude mouse models Mol Imaging Biol 13 112 120 1:CAS:528:DC%2BC3cXlvVKhurg%3D
104. SK Kuwada 2007 Drug evaluation: volociximab, an angiogenesis-inhibiting chimeric monoclonal antibody Curr Opin Mol Ther 9 92 98 17330407 1:CAS:528:DC%2BD2sXjt1Sgtr0%3D (Pubitemid 46438452)
105. AD Ricart AW Tolcher G Liu K Holen G Schwartz M Albertini G Weiss S Yazji C Ng G Wilding 2008 Volociximab, a chimeric monoclonal antibody that specifically binds alpha5beta1 integrin: a phase I, pharmacokinetic, and biological correlative study Clin Cancer Res 14 7924 7929 19047123 1:CAS:528:DC%2BD1cXhsVegt7%2FN
106. Q Chen CD Manning H Millar FL McCabe C Ferrante C Sharp L Shahied-Arruda P Doshi MT Nakada GM Anderson 2008 CNTO 95, a fully human anti alphav integrin antibody, inhibits cell signaling, migration, invasion, and spontaneous metastasis of human breast cancer cells Clin Exp Metastasis 25 139 148 18064530 1:CAS:528:DC%2BD1cXmtFyhtbk%3D
107. S Ning JA Nemeth RL Hanson K Forsythe SJ Knox 2008 Anti-integrin monoclonal antibody CNTO 95 enhances the therapeutic efficacy of fractionated radiation therapy in vivo Mol Cancer Ther 7 1569 1578 18566227 1:CAS:528:DC%2BD1cXnsVSktb4%3D
108. PA Burke SJ DeNardo LA Miers KR Lamborn S Matzku GL DeNardo 2002 Cilengitide targeting of alpha(v)beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts Cancer Res 62 4263 4272 12154028 1:CAS:528:DC%2BD38XlvFeltbw%3D (Pubitemid 34827281)
109. FA Eskens H Dumez R Hoekstra A Perschl C Brindley S Bottcher W Wynendaele J Drevs J Verweij AT van Oosterom 2003 Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins alphavbeta3 and alphavbeta5 in patients with advanced solid tumours Eur J Cancer 39 917 926 12706360 1:CAS:528: DC%2BD3sXivFCktL0%3D (Pubitemid 36428623)
110. JM Albert C Cao L Geng L Leavitt DE Hallahan B Lu 2006 Integrin alpha v beta 3 antagonist Cilengitide enhances efficacy of radiotherapy in endothelial cell and non-small-cell lung cancer models Int J Radiat Oncol Biol Phys 65 1536 1543 16863930 1:CAS:528:DC%2BD28Xntl2is7c%3D (Pubitemid 44425239)
111. TJ MacDonald CF Stewart M Kocak S Goldman RG Ellenbogen P Phillips D Lafond TY Poussaint MW Kieran JM Boyett LE Kun 2008 Phase I clinical trial of cilengitide in children with refractory brain tumors: Pediatric Brain Tumor Consortium Study PBTC-012 J Clin Oncol 26 919 924 18281665 1:CAS:528: DC%2BD1cXjtFeltrg%3D (Pubitemid 351398085)
112. Bradley DA, Daignault S, Ryan CJ, Dipaola RS, Smith DC, Small E, Gross ME, Stein MN, Chen A, Hussain M (2010) Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium. Investig New Drugs
113. P Khalili A Arakelian G Chen ML Plunkett I Beck GC Parry F Donate DE Shaw AP Mazar SA Rabbani 2006 A non-RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo Mol Cancer Ther 5 2271 2280 16985061 1:CAS:528:DC%2BD28Xps1ynsL0%3D (Pubitemid 44530464)
114. F Donate GC Parry Y Shaked H Hensley X Guan I Beck Z Tel-Tsur ML Plunkett M Manuia DE Shaw RS Kerbel AP Mazar 2008 Pharmacology of the novel antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2): observation of a U-shaped dose-response curve in several preclinical models of angiogenesis and tumor growth Clin Cancer Res 14 2137 2144 18381955 1:CAS:528:DC%2BD1cXkt1aku7Y%3D (Pubitemid 351551126)
115. PJ Coleman KM Brashear BC Askew JH Hutchinson CA McVean T Duong le BP Feuston C Fernandez-Metzler MA Gentile GD Hartman DB Kimmel CT Leu L Lipfert K Merkle B Pennypacker T Prueksaritanont GA Rodan GA Wesolowski SB Rodan ME Duggan 2004 Nonpeptide alphavbeta3 antagonists. Part 11: discovery and preclinical evaluation of potent alphavbeta3 antagonists for the prevention and treatment of osteoporosis J Med Chem 47 4829 4837 15369386 1:CAS:528:DC%2BD2cXmvFChtbY%3D (Pubitemid 39238257)
116. DM O'Hanlon H Fitzsimons J Lynch S Tormey C Malone HF Given 2002 Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma Eur J Cancer 38 2252 2257 12441261 (Pubitemid 35346466)
117. C Schroder U Schumacher M Fogel F Feuerhake V Muller RM Wirtz P Altevogt S Krenkel F Janicke K Milde-Langosch 2009 Expression and prognostic value of L1-CAM in breast cancer Oncol Rep 22 1109 1117 19787228
118. WA Osta Y Chen K Mikhitarian M Mitas M Salem YA Hannun DJ Cole WE Gillanders 2004 EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy Cancer Res 64 5818 5824 15313925 1:CAS:528:DC%2BD2cXmslaks74%3D (Pubitemid 39095582)
119. A Cimino M Halushka P Illei X Wu S Sukumar P Argani 2009 Epithelial cell adhesion molecule (EpCAM) is overexpressed in breast cancer metastases Breast Cancer Res Treat 123 3 701 708 20012351
120. G Spizzo P Went S Dirnhofer P Obrist R Simon H Spichtin R Maurer U Metzger B von Castelberg R Bart S Stopatschinskaya OR Kochli P Haas F Mross M Zuber H Dietrich S Bischoff M Mirlacher G Sauter G Gastl 2004 High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer Breast Cancer Res Treat 86 207 213 15567937 1:CAS:528:DC%2BD2cXmt1Kqt74%3D (Pubitemid 39070963)
121. HC Silva F Garcao EC Coutinho CF De Oliveira FJ Regateiro 2006 Soluble VCAM-1 and E-selectin in breast cancer: relationship with staging and with the detection of circulating cancer cells Neoplasma 53 538 543 17167725 1:CAS:528:DC%2BD2sXhsVOlsbg%3D (Pubitemid 46133516)
122. M Uehara T Kinoshita T Hojo S Akashi-Tanaka E Iwamoto T Fukutomi 2008 Long-term prognostic study of carcinoembryonic antigen (CEA) and carbohydrate antigen 15-3 (CA 15-3) in breast cancer Int J Clin Oncol 13 447 451 18946756 1:CAS:528:DC%2BD1cXht1OktrzF
123. L Shapiro PD Kwong AM Fannon DR Colman WA Hendrickson 1995 Considerations on the Folding Topology and Evolutionary Origin of Cadherin Domains Proc Natl Acad Sci USA 92 6793 6797 7624321 1:CAS:528:DyaK2MXntVSks7Y%3D
124. JJ Perez 2011 Is the folding topology of a protein related to its amino acid occurrence? J Biomol Struct Dyn 28 657 659 21142252 1:CAS:528: DC%2BC3MXhtlCnurg%3D
125. Q Shen JJ Rahn J Zhang N Gunasekera X Sun AR Shaw MJ Hendzel P Hoffman A Bernier JC Hugh 2008 MUC1 initiates Src-CrkL-Rac1/Cdc42-mediated actin cytoskeletal protrusive motility after ligating intercellular adhesion molecule-1 Mol Cancer Res 6 555 567 18403635 1:CAS:528:DC%2BD1cXksFKms7w%3D (Pubitemid 351521837)
126. JJ Rahn Q Shen BK Mah JC Hugh 2004 MUC1 initiates a calcium signal after ligation by intercellular adhesion molecule-1 J Biol Chem 279 29386 29390 15169768 1:CAS:528:DC%2BD2cXlsVCmtLo%3D (Pubitemid 38915817)
127. JJ Rahn JW Chow GJ Horne BK Mah JT Emerman P Hoffman JC Hugh 2005 MUC1 mediates transendothelial migration in vitro by ligating endothelial cell ICAM-1 Clin Exp Metastasis 22 475 483 16320110 1:CAS:528:DC%2BD28XhsVaqsLY%3D (Pubitemid 41750699)
128. PW Thompson AM Randi AJ Ridley 2002 Intercellular adhesion molecule (ICAM)-1, but not ICAM-2, activates RhoA and stimulates c-fos and rhoA transcription in endothelial cells J Immunol 169 1007 1013 12097408 1:CAS:528:DC%2BD38XlsVWjsLw%3D (Pubitemid 34753460)
129. Y Kawai M Kaidoh T Ohhashi 2008 MDA-MB-231 produces ATP-mediated ICAM-1-dependent facilitation of the attachment of carcinoma cells to human lymphatic endothelial cells Am J Physiol Cell Physiol 295 C1123 C1132 18768924 1:CAS:528:DC%2BD1cXhsVWkurrF
130. Y Kawai M Kaidoh Y Yokoyama K Sano T Ohhashi 2009 Chemokine CCL2 facilitates ICAM-1-mediated interactions of cancer cells and lymphatic endothelial cells in sentinel lymph nodes Cancer Sci 100 419 428 19154405 1:CAS:528:DC%2BD1MXjt1WrtLo%3D
131. S Schmidt P Friedl 2010 Interstitial cell migration: integrin-dependent and alternative adhesion mechanisms Cell Tissue Res 339 83 92 19921267 1:CAS:528:DC%2BD1MXhsVymtrjL
132. A Afify MA McNiel J Braggin H Bailey AF Paulino 2008 Expression of CD44s,
133. J Rys A Kruczak B Lackowska A Jaszcz-Gruchala A Brandys A Stelmach M Reinfuss 2003 The role of CD44v3 expression in female breast carcinomas Pol J Pathol 54 243 247 14998292 (Pubitemid 38233129)
134. A Afify P Purnell L Nguyen 2009 Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion Exp Mol Pathol 86 95 100 19167378 1:CAS:528:DC%2BD1MXjslKrtrs%3D
135. HS Wang Y Hung CH Su ST Peng YJ Guo MC Lai CY Liu JW Hsu 2005 CD44 cross-linking induces integrin-mediated adhesion and transendothelial migration in breast cancer cell line by up-regulation of LFA-1 (alpha L beta2) and VLA-4 (alpha4beta1) Exp Cell Res 304 116 126 15707579 1:CAS:528:DC%2BD2MXhtFOmsb4%3D (Pubitemid 40222081)
136. ST Peng CH Su CC Kuo CF Shaw HS Wang 2007 CD44 crosslinking-mediated matrix metalloproteinase-9 relocation in breast tumor cells leads to enhanced metastasis Int J Oncol 31 1119 1126 17912438 1:CAS:528:DC%2BD2sXhtlKhsrfJ
137. V Thanakit P Sampatanukul P Ruangvejvorachai S Keelawat 2005 The association of co-expression of CD44v4/MMP-9 with different nodal status in high-grade breast carcinoma patients J Med Assoc Thail 88 Suppl 4 S30 S35
138. SA Mullamitha NC Ton GJ Parker A Jackson PJ Julyan C Roberts GA Buonaccorsi Y Watson K Davies S Cheung L Hope JW Valle JA Radford J Lawrance MP Saunders MC Munteanu MT Nakada JA Nemeth HM Davis Q Jiao U Prabhakar Z Lang RE Corringham RA Beckman GC Jayson 2007 Phase I evaluation of a fully human anti-alphav integrin monoclonal antibody (CNTO 95) in patients with advanced solid tumors Clin Cancer Res 13 2128 2135 17404096 1:CAS:528: DC%2BD2sXjs12rt7k%3D (Pubitemid 46649882)